Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1994 Jul;32(7):1779–1782. doi: 10.1128/jcm.32.7.1779-1782.1994

Tentative evidence of AIDS-associated biotype of Mycobacterium kansasii.

E Tortoli 1, M T Simonetti 1, C Lacchini 1, V Penati 1, P Urbano 1
PMCID: PMC263792  PMID: 7929774

Abstract

Previous studies revealed heterogeneous behavior within the species Mycobacterium kansasii against commercially available DNA probes (Accuprobe M. kansasii culture identification test; Gen-Probe); several isolates, conventionally identified as M. kansasii, failed in fact to hybridize. Looking for a possible association with phenotypic features, we tested a fully characterized panel of 69 clinical isolates of M. kansasii (19 of which were Accuprobe negative) with a semiquantitative micromethod which tests for 19 enzymatic activities (Api Zym; BioMérieux). The strains were from 25 hospitals in 18 Italian towns; 20 isolates came from human immunodeficiency virus type 1-positive patients who fulfilled the Centers for Disease Control criteria for AIDS diagnosis. On the basis of the whole set of phenotypic traits, our strains clustered in two groups, allowing the differentiation of biotypes within the species. There was a perfect association between biotype 2 and hybridization failures with Accuprobe and a very significant association between this novel biotype 2 and AIDS status, which suggests that it differs in virulence.

Full text

PDF
1782

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Lebrun L., Espinasse F., Poveda J. D., Vincent-Levy-Frebault V. Evaluation of nonradioactive DNA probes for identification of mycobacteria. J Clin Microbiol. 1992 Sep;30(9):2476–2478. doi: 10.1128/jcm.30.9.2476-2478.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Nachamkin I., MacGregor R. R., Staneck J. L., Tsang A. Y., Denner J. C., Willner M., Barbagallo S. Niacin-positive Mycobacterium kansasii isolated from immunocompromised patients. J Clin Microbiol. 1992 May;30(5):1344–1346. doi: 10.1128/jcm.30.5.1344-1346.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ross B. C., Jackson K., Yang M., Sievers A., Dwyer B. Identification of a genetically distinct subspecies of Mycobacterium kansasii. J Clin Microbiol. 1992 Nov;30(11):2930–2933. doi: 10.1128/jcm.30.11.2930-2933.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Tortoli E., Simonetti M. T., Lacchini C., Penati V., Piersimoni C., Morbiducci V. Evaluation of a commercial DNA probe assay for the identification of Mycobacterium kansasii. Eur J Clin Microbiol Infect Dis. 1994 Mar;13(3):264–267. doi: 10.1007/BF01974549. [DOI] [PubMed] [Google Scholar]
  5. Valainis G. T., Cardona L. M., Greer D. L. The spectrum of Mycobacterium kansasii disease associated with HIV-1 infected patients. J Acquir Immune Defic Syndr. 1991;4(5):516–520. [PubMed] [Google Scholar]
  6. WAYNE L. G. Two varieties of Mycobacterium kansasii with different clinical significance. Am Rev Respir Dis. 1962 Nov;86:651–656. doi: 10.1164/arrd.1962.86.5.651. [DOI] [PubMed] [Google Scholar]
  7. Yang M., Ross B. C., Dwyer B. Identification of an insertion sequence-like element in a subspecies of Mycobacterium kansasii. J Clin Microbiol. 1993 Aug;31(8):2074–2079. doi: 10.1128/jcm.31.8.2074-2079.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES